Company / Gross Profit
Abbott Laboratories Gross Profit History
FY2016-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$3.7B
FY2018
5-year range
-
FY2016-FY2018
Trend
+35.0%
vs FY2017
Sector context
#15 of 100
Health Care
What the data says
Abbott Laboratories's gross profit of $3.7B is higher than 85% of companies in the Health Care sector (FY2018). Improved from $2.6B to $3.7B over the past 2 years.
Based on SEC 10-K filings.
$3.7B in FY2018. Top quartile in the Health Care sector.
Improved from $2.6B to $3.7B over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 100This company $3.7B Sector average $1.8B
▼
+105.8% above sector average
Key checks
Key Insights
- In FY2018, gross profit increased 35.0% year-over-year.
- Ranks #15 out of 100 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 31.9%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 27.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $3.7B | +35.0% |
| FY2017 | $2.8B | +6.5% |
| FY2016 | $2.6B | -2.2% |
As of FY2018 · SEC 10-K · Updated Jun 30, 2026